...
首页> 外文期刊>The Journal of Allergy and Clinical Immunology >Problem solving to improve adherence and asthma outcomes in urban adults with moderate or severe asthma: a randomized controlled trial.
【24h】

Problem solving to improve adherence and asthma outcomes in urban adults with moderate or severe asthma: a randomized controlled trial.

机译:在中度或重度哮喘城市成年人中解决问题以改善依从性和哮喘结果的一项随机对照试验。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Improving inhaled corticosteroid (ICS) adherence should improve asthma outcomes. OBJECTIVE: In a randomized controlled trial we tested whether an individualized problem-solving (PS) intervention improves ICS adherence and asthma outcomes. METHODS: Adults with moderate or severe asthma from clinics serving urban neighborhoods were randomized to PS (ie, defining specific barriers to adherence, proposing/weighing solutions, trying the best, assessing, and revising) or standard asthma education (AE) for 3 months and then observed for 3 months. Adherence was monitored electronically. Outcomes included the following: asthma control, FEV(1), asthma-related quality of life, emergency department (ED) visits, and hospitalizations. In an intention-to-treat-analysis longitudinal models using random effects and regression were used. RESULTS: Three hundred thirty-three adults were randomized: 49 +/- 14 years of age, 72% female, 68% African American, 7% Latino, mean FEV(1) of 66% +/- 19%, and 103 (31%) with hospitalizations and 172 (52%) with ED visits for asthma in the prior year. There was no difference between groups in overall change in any outcome (P > .20). Mean adherence (61% +/- 27%) decreased significantly (P = .0004) over time by 14% and 10% in the AE and PS groups, respectively. Asthma control improved overall by 15% (P = .002). In both groups FEV(1) and quality of life improved by 6% (P = .01) and 18% (P < .0001), respectively. However, the improvement in FEV(1) only occurred during monitoring but not subsequently after randomization. Rates of ED visits and hospitalizations did not significantly decrease over the study period. CONCLUSION: PS was not better than AE in improving adherence or asthma outcomes. However, monitoring ICS use with provision of medications and attention, which was imposed on both groups, was associated with improvement in FEV(1) and asthma control.
机译:背景:改善吸入性糖皮质激素(ICS)依从性应改善哮喘预后。目的:在一项随机对照试验中,我们测试了个性化解决问题(PS)干预措施能否改善ICS依从性和哮喘预后。方法:将在市区附近诊所中患有中度或重度哮喘的成年人随机分配至PS(即确定依从性的具体障碍,提出/权衡解决方案,尽力而为,评估和修订)或标准哮喘教育(AE)3个月然后观察3个月。依从性进行电子监控。结果包括以下内容:哮喘控制,FEV(1),与哮喘有关的生活质量,急诊就诊和住院治疗。在意向性治疗分析中,使用了使用随机效应和回归的纵向模型。结果:333名成年人被随机分组​​:49 +/- 14岁,女性72%,非裔美国人68%,拉丁裔7%,平均FEV(1)为66%+/- 19%,和103(上一年有31%的患者住院治疗,急诊就诊的有172位患者(52%)。两组之间任何结果的总体变化均无差异(P> .20)。 AE和PS组的平均依从性(61%+/- 27%)随时间显着下降(P = .0004),分别降低了14%和10%。哮喘控制总体改善了15%(P = .002)。在两组中,FEV(1)和生活质量分别提高了6%(P = .01)和18%(P <.0001)。但是,FEV(1)的改善仅在监视期间发生,而在随后的随机化之后并未发生。在研究期间,急诊就诊和住院率没有显着下降。结论:PS在改善依从性或哮喘结局方面并不优于AE。但是,对两组患者都进行药物和注意力监测以监测ICS的使用与FEV(1)和哮喘控制的改善相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号